Economic evaluation of type 2 diabetes mellitus burden and its main cardiovascular complications in the Russian Federation

Background. Diabetes Mellitus Type 2 (DMT2) is a complex medical and social problem in the world and in the Russian Federation also due to prevalence and probability of cardio-vascular complications (CVC).Aim. Economic burden evaluation of DMT2 in the Russian Federation.Methods. Complex analysis of...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Ivan I. Dedov, Anna V. Koncevaya, Marina V. Shestakova, Yuriy B. Belousov, Julia A. Balanova, Mikhail B. Khudyakov, Oleg I. Karpov
Formato:	article
Lenguaje:	EN RU
Publicado:	Endocrinology Research Centre 2016
Materias:	diabetes mellitus type 2 health care system economics cost of illness Nutritional diseases. Deficiency diseases RC620-627
Acceso en línea:	https://doaj.org/article/91b40641d3e84f8ab2e700fb69ae0e9f
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:91b40641d3e84f8ab2e700fb69ae0e9f
record_format	dspace
spelling	oai:doaj.org-article:91b40641d3e84f8ab2e700fb69ae0e9f2021-11-14T09:00:20ZEconomic evaluation of type 2 diabetes mellitus burden and its main cardiovascular complications in the Russian Federation2072-03512072-037810.14341/DM8153https://doaj.org/article/91b40641d3e84f8ab2e700fb69ae0e9f2016-12-01T00:00:00Zhttps://www.dia-endojournals.ru/jour/article/view/8153https://doaj.org/toc/2072-0351https://doaj.org/toc/2072-0378Background. Diabetes Mellitus Type 2 (DMT2) is a complex medical and social problem in the world and in the Russian Federation also due to prevalence and probability of cardio-vascular complications (CVC).Aim. Economic burden evaluation of DMT2 in the Russian Federation.Methods. Complex analysis of expenditures (direct and non-direct costs) based on epidemiological, pharmacoeconomics and clinical investigations, population and medical statistics data.Results. Calculated expenditures for DMT2 are 569 bln RUR per year, that is correspond to 1% of the Russian GDP, and 34,7% of that are expenditures for main CVC (ischemic heart disease, cardiac infarction, stroke). Main part of expenses are non-medical (losses GDP) due to temporary and permanent disability, untimely mortality – 426,7 bln RUR per year. Expenditures in estimated group of patients with non-diagnosed DMT2 but with already having CVC were at least 107 bln per year (18,8% from total cost). Relationship between cost of DMT2 and degree of it’s control was found in the Russian conditions. Estimated cost for compensated patient (HbA1c<6,5%) per year was 88 982 RUR, in the same time cost of non-control patient (HbA1c>9,5%) was in 2,8 times higher due to more often main CVC in this group.Conclusion. DMT2 diagnosis improvement as well as effective treatment of early stages of illness can decrease probability of CVC and social economic expenditures.Ivan I. DedovAnna V. KoncevayaMarina V. ShestakovaYuriy B. BelousovJulia A. BalanovaMikhail B. KhudyakovOleg I. KarpovEndocrinology Research Centrearticlediabetes mellitus type 2health care system economicscost of illnessNutritional diseases. Deficiency diseasesRC620-627ENRUСахарный диабет, Vol 19, Iss 6, Pp 518-527 (2016)
institution	DOAJ
collection	DOAJ
language	EN RU
topic	diabetes mellitus type 2 health care system economics cost of illness Nutritional diseases. Deficiency diseases RC620-627
spellingShingle	diabetes mellitus type 2 health care system economics cost of illness Nutritional diseases. Deficiency diseases RC620-627 Ivan I. Dedov Anna V. Koncevaya Marina V. Shestakova Yuriy B. Belousov Julia A. Balanova Mikhail B. Khudyakov Oleg I. Karpov Economic evaluation of type 2 diabetes mellitus burden and its main cardiovascular complications in the Russian Federation
description	Background. Diabetes Mellitus Type 2 (DMT2) is a complex medical and social problem in the world and in the Russian Federation also due to prevalence and probability of cardio-vascular complications (CVC).Aim. Economic burden evaluation of DMT2 in the Russian Federation.Methods. Complex analysis of expenditures (direct and non-direct costs) based on epidemiological, pharmacoeconomics and clinical investigations, population and medical statistics data.Results. Calculated expenditures for DMT2 are 569 bln RUR per year, that is correspond to 1% of the Russian GDP, and 34,7% of that are expenditures for main CVC (ischemic heart disease, cardiac infarction, stroke). Main part of expenses are non-medical (losses GDP) due to temporary and permanent disability, untimely mortality – 426,7 bln RUR per year. Expenditures in estimated group of patients with non-diagnosed DMT2 but with already having CVC were at least 107 bln per year (18,8% from total cost). Relationship between cost of DMT2 and degree of it’s control was found in the Russian conditions. Estimated cost for compensated patient (HbA1c<6,5%) per year was 88 982 RUR, in the same time cost of non-control patient (HbA1c>9,5%) was in 2,8 times higher due to more often main CVC in this group.Conclusion. DMT2 diagnosis improvement as well as effective treatment of early stages of illness can decrease probability of CVC and social economic expenditures.
format	article
author	Ivan I. Dedov Anna V. Koncevaya Marina V. Shestakova Yuriy B. Belousov Julia A. Balanova Mikhail B. Khudyakov Oleg I. Karpov
author_facet	Ivan I. Dedov Anna V. Koncevaya Marina V. Shestakova Yuriy B. Belousov Julia A. Balanova Mikhail B. Khudyakov Oleg I. Karpov
author_sort	Ivan I. Dedov
title	Economic evaluation of type 2 diabetes mellitus burden and its main cardiovascular complications in the Russian Federation
title_short	Economic evaluation of type 2 diabetes mellitus burden and its main cardiovascular complications in the Russian Federation
title_full	Economic evaluation of type 2 diabetes mellitus burden and its main cardiovascular complications in the Russian Federation
title_fullStr	Economic evaluation of type 2 diabetes mellitus burden and its main cardiovascular complications in the Russian Federation
title_full_unstemmed	Economic evaluation of type 2 diabetes mellitus burden and its main cardiovascular complications in the Russian Federation
title_sort	economic evaluation of type 2 diabetes mellitus burden and its main cardiovascular complications in the russian federation
publisher	Endocrinology Research Centre
publishDate	2016
url	https://doaj.org/article/91b40641d3e84f8ab2e700fb69ae0e9f
work_keys_str_mv	AT ivanidedov economicevaluationoftype2diabetesmellitusburdenanditsmaincardiovascularcomplicationsintherussianfederation AT annavkoncevaya economicevaluationoftype2diabetesmellitusburdenanditsmaincardiovascularcomplicationsintherussianfederation AT marinavshestakova economicevaluationoftype2diabetesmellitusburdenanditsmaincardiovascularcomplicationsintherussianfederation AT yuriybbelousov economicevaluationoftype2diabetesmellitusburdenanditsmaincardiovascularcomplicationsintherussianfederation AT juliaabalanova economicevaluationoftype2diabetesmellitusburdenanditsmaincardiovascularcomplicationsintherussianfederation AT mikhailbkhudyakov economicevaluationoftype2diabetesmellitusburdenanditsmaincardiovascularcomplicationsintherussianfederation AT olegikarpov economicevaluationoftype2diabetesmellitusburdenanditsmaincardiovascularcomplicationsintherussianfederation
_version_	1718429544771223552

Economic evaluation of type 2 diabetes mellitus burden and its main cardiovascular complications in the Russian Federation

Ejemplares similares